Sporadic/chemical induced |
|
|
Carcinogens in situ |
|
|
Peritoneum models |
|
-
✓
Biological behavior does not mimic/replicate human tumors
-
✓
Biological behavior difficult to predict, usually with disseminated and advanced disease
|
Subcutaneous xenografts |
|
-
✓
Heterotopic inoculation of the tumor is not a physiologic process
-
✓
Low immune system activity
-
✓
Tumoral cancer cells and stromal cells are from different species
-
✓
Nonmetastatic
-
✓
Difficult to predict the response to antitumoral drugs
|
Orthotopic xenografts |
-
✓
Use of human cancer cells
-
✓
Histology is similar to the human tumors
-
✓
Metastatic potential
-
✓
Replicates the local invasion process by the tumor, with lymphovascular invasion
-
✓
Allows genetic manipulation
|
-
✓
Low immune system activity
-
✓
Tumoral cancer cells and stromal cells are from different species
-
✓
Unable to replicate the initial steps of disease
-
✓
Less tumor formation than subcutaneous xenografts
-
✓
Difficult to predict the response to antitumoral drugs
|
Syngenic |
|
|
Genetic engineered mouse models |
-
✓
Genetic event is known
-
✓
In situ tumor development
-
✓
Reproduces early stages of oncogenesis
-
✓
Modified gene is expressed on physiologic level
-
✓
Tumor cells and stroma are from the same specie
-
✓
Intact immune system
-
✓
Used for chemoprevention studies
|
-
✓
Only partial replication of the human tumoral morphology and physiology
-
✓
Secondary mutations are different from the human tumors
-
✓
Rarely metastatic
-
✓
Response capacity to antitumoral drugs still unknown
|